Article info
PDFOriginal article
Hospital admissions for bleeding events associated with treatment with apixaban, dabigatran and rivaroxaban
- Correspondence to Dr Manuel Koninckx Cañada, Department of Hospital Pharmacy, Francesc de Borja Hospital of Gandia, Gandia, 46701 Valencia, Spain; koninchk_man{at}gva.es
Citation
Hospital admissions for bleeding events associated with treatment with apixaban, dabigatran and rivaroxaban
Publication history
- Received August 24, 2017
- Revised September 22, 2017
- Accepted October 10, 2017
- First published October 30, 2017.
Online issue publication
May 01, 2020
Article Versions
- Previous version (21 February 2019).
- Previous version (21 February 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists (unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.